PHI granted patent on synthetic antibodies in the U.S.
Phase Holographic Imaging AB (PHI) announces today that the Company has been granted a patent (US10730986B2 ) on synthetic antibodies from the United States Patent and Trademark Office (USPTO). PHI submitted the patent application "Molecularly Imprinted Polymers" together with Germany’s federal institute for materials research (BAM) to the USPTO on November 20, 2017."The approval of the patent in the U.S. marks a significant milestone for the